Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.

Goodnow RA Jr, Hicks A, Sidduri A, Kowalczyk A, Dominique R, Qiao Q, Lou JP, Gillespie P, Fotouhi N, Tilley J, Cohen N, Choudhry S, Cavallo G, Tannu SA, Ventre JD, Lavelle D, Tare NS, Oh H, Lamb M, Kurylko G, Hamid R, Wright MB, Pamidimukkala A, Egan T, Gubler U, Hoffman AF, Wei X, Li YL, O'Neil J, Marcano R, Pozzani K, Molinaro T, Santiago J, Singer L, Hargaden M, Moore D, Catala AR, Chao LC, Hermann G, Venkat R, Mancebo H, Renzetti LM.

J Med Chem. 2010 May 13;53(9):3502-16. doi: 10.1021/jm1001919.

PMID:
20380377
2.

Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates.

Hicks A, Goodnow R Jr, Cavallo G, Tannu SA, Ventre JD, Lavelle D, Lora JM, Satjawatcharaphong J, Brovarney M, Dabbagh K, Tare NS, Oh H, Lamb M, Sidduri A, Dominique R, Qiao Q, Lou JP, Gillespie P, Fotouhi N, Kowalczyk A, Kurylko G, Hamid R, Wright MB, Pamidimukkala A, Egan T, Gubler U, Hoffman AF, Wei X, Li YL, O'Neil J, Marcano R, Pozzani K, Molinaro T, Santiago J, Singer L, Hargaden M, Moore D, Catala AR, Chao LC, Benson J, March T, Venkat R, Mancebo H, Renzetti LM.

Prostaglandins Other Lipid Mediat. 2010 Jun;92(1-4):33-43. doi: 10.1016/j.prostaglandins.2010.02.003. Epub 2010 Mar 7.

PMID:
20214997
3.

Opportunities and challenges of developing peptide drugs in the pharmaceutical industry.

Danho W, Swistok J, Khan W, Chu XJ, Cheung A, Fry D, Sun H, Kurylko G, Rumennik L, Cefalu J, Cefalu G, Nunn P.

Adv Exp Med Biol. 2009;611:467-9. No abstract available.

PMID:
19400268
4.

Preparation of human Melanocortin-4 receptor agonist libraries: linear peptides X-Y-DPhe7-Arg8-Trp(or 2-Nal)9-Z-NH2.

Cheung AW, Qi L, Gore V, Chu XJ, Bartkovitz D, Kurylko G, Swistok J, Danho W, Chen L, Yagaloff K.

Bioorg Med Chem Lett. 2005 Dec 15;15(24):5504-8. Epub 2005 Oct 3.

PMID:
16203134
5.

Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.

Chu XJ, Bartkovitz D, Danho W, Swistok J, Cheung AW, Kurylko G, Rowan K, Yeon M, Franco L, Qi L, Chen L, Yagaloff K.

Bioorg Med Chem Lett. 2005 Nov 15;15(22):4910-4.

PMID:
16169218
6.

Structure-activity relationship of cyclic peptide penta-c[Asp-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys]-NH(2) at the human melanocortin-1 and -4 receptors: His(6) substitution.

Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Rowan K, Yeon M, Franco L, Chu XJ, Chen L, Yagaloff K.

Bioorg Med Chem Lett. 2003 Apr 7;13(7):1307-11.

PMID:
12657270
7.

Structure-activity relationship of linear peptide Bu-His6-DPhe7-Arg8-Trp9-Gly10-NH2 at the human melanocortin-1 and -4 receptors: DPhe7 and Trp9 substitution.

Danho W, Swistok J, Cheung AW, Kurylko G, Franco L, Chu XJ, Chen L, Yagaloff K.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):649-52.

PMID:
12639550
8.

Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.

Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Rowan K, Yeon M, Franco L, Chu XJ, Chen L, Yagaloff K.

Bioorg Med Chem Lett. 2003 Jan 6;13(1):133-7.

PMID:
12467633
9.

Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: arginine substitution.

Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Franco L, Yagaloff K, Chen L.

Bioorg Med Chem Lett. 2002 Sep 2;12(17):2407-10.

PMID:
12161144
10.

A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences.

Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W, Seeley RJ.

J Neurosci. 2000 May 1;20(9):3442-8.

Supplemental Content

Loading ...
Support Center